Rucaparib Not Yet Recruiting Phase 2 Trials for Endometrial Cancers Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03694262The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)